SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+7.05%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$427M
AUM Growth
+$427M
(+54%)
Cap. Flow
+$139M
Cap. Flow
% of AUM
32.43%
Top 10 Holdings %
Top 10 Hldgs %
57.06%
Holding
143
New
47
Increased
27
Reduced
21
Closed
35
Top Buys
| 1 |
Novartis
NVS
|
$42.9M |
| 2 |
Sanofi
SNY
|
$33.4M |
| 3 |
Johnson & Johnson
JNJ
|
$21.2M |
| 4 |
Eli Lilly
LLY
|
$17.7M |
| 5 |
Merck
MRK
|
$14.2M |
Top Sells
| 1 |
SHPG
Shire pic
SHPG
|
$9.18M |
| 2 |
iShares Russell 2000 ETF
IWM
|
$7.75M |
| 3 |
Invesco QQQ Trust
QQQ
|
$7.1M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$4.67M |
| 5 |
Apple
AAPL
|
$3.1M |
Sector Composition
| 1 | Healthcare | 75.14% |
| 2 | Consumer Discretionary | 3.07% |
| 3 | Technology | 2.73% |
| 4 | Industrials | 1.88% |
| 5 | Consumer Staples | 1.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Novartis
NVS
$245B
| $45.4M | 10.37% | 535,100 +505,100 | +1,684% | +$42.9M |
|
2
GSK
GSK
$79.9B
| $34.7M | 7.93% | 650,000 +100,000 | +18% | +$5.34M |
|
|
3
Sanofi
SNY
$121B
| $33.4M | 7.62% | +320,000 | New | +$33.4M |
|
|
4
Merck
MRK
$210B
| $30.1M | 6.87% | 530,000 +250,000 | +89% | +$14.2M |
|
5
Pfizer
PFE
$141B
| $27.5M | 6.27% | 854,596 +152,100 | +22% | +$4.89M |
|
|
6
Johnson & Johnson
JNJ
$427B
| $22M | 5.01% | 223,600 +215,800 | +2,767% | +$21.2M |
|
|
7
Eli Lilly
LLY
$657B
| $17.7M | 4.03% | +300,000 | New | +$17.7M |
|
8
Financial Select Sector SPDR Fund
XLF
$54.1B
| $15.2M | 3.47% | 680,659 -82,197 | -11% | -$1.84M |
|
9
Health Care Select Sector SPDR Fund
XLV
$33.9B
| $9.32M | 2.13% | 159,353 +23,330 | +17% | +$1.36M |
|
10
Amgen
AMGN
$155B
| $8.63M | 1.97% | 70,000 | – | – |
|
11
Gilead Sciences
GILD
$140B
| $6.66M | 1.52% | 94,000 | – | – |
|
|
SGEN
12
DELISTED
Seagen Inc. Common Stock
SGEN
| $5.82M | 1.33% | 127,800 +5,000 | +4% | +$228K |
|
13
Perrigo
PRGO
$3.27B
| $5.58M | 1.27% | +36,106 | New | +$5.58M |
|
14
Biogen
BIIB
$19.4B
| $5.2M | 1.19% | 17,000 +5,000 | +42% | +$1.53M |
|
15
United Therapeutics
UTHR
$13.8B
| $4.7M | 1.07% | +50,000 | New | +$4.7M |
|
16
TJX Companies
TJX
$152B
| $4.54M | 1.04% | 74,916 +9,700 | +15% | +$588K |
|
17
Incyte
INCY
$16.5B
| $4.44M | 1.01% | 83,000 -47,000 | -36% | -$2.52M |
|
18
Colgate-Palmolive
CL
$67.9B
| $4.07M | 0.93% | 62,799 +9,500 | +18% | +$616K |
|
19
Nike
NKE
$114B
| $3.66M | 0.84% | 49,544 +34,550 | +230% | +$2.55M |
|
20
Energy Select Sector SPDR Fund
XLE
$27.6B
| $3.56M | 0.81% | +40,000 | New | +$3.56M |
|
|
BRCM
21
DELISTED
BROADCOM CORP CL-A
BRCM
| $3.54M | 0.81% | 112,500 +16,500 | +17% | +$519K |
|
22
SPDR Euro Stoxx 50 ETF
FEZ
$4.54B
| $3.54M | 0.81% | +83,000 | New | +$3.54M |
|
|
ORBK
23
DELISTED
Orbotech Ltd
ORBK
| $3.44M | 0.78% | 223,174 +16,420 | +8% | +$253K |
|
|
WBA
24
DELISTED
Walgreens Boots Alliance
WBA
| $3.4M | 0.78% | 51,453 +16,153 | +46% | +$1.07M |
|
25
CSX Corp
CSX
$60.6B
| $3.38M | 0.77% | 116,825 +43,500 | +59% | +$1.26M |
|